logo
Queensland's homeschooling parents pleased with outcome from review

Queensland's homeschooling parents pleased with outcome from review

SBS Australia25-07-2025
A win for homeschooling parents in Queensland, fighting to make the system more accessible for families. The Queensland government has accepted all 8 recommendations of an independent review into the Home Education Unit. The regulatory review, which published its report in September 2024, was prompted by widespread opposition to the previous state government's attempts to enforce legislation that would impose the Australian curriculum on homeschooling students. That move was firmly rejected by parents like Danika, who homeschools her neurodiverse 8-year-old son Ben. Danika says she's most excited about a recommendation to trial a shorter style of written reporting, alongside an online interview. She says this would offer a promising alternative for Queensland parents, after a positive experience with a moderator while homeschooling in Western Australia. "Whereas in Queensland, you feel it's just cross your fingers and hope that you can continue to do, and there's a lot of uncertainty around the processes over here, and it is quite daunting to submit a report every 12 months with no real guidance, no real reassurance that you are doing what they require. Having a person to report to would be humanising to the procedure, so that would be quite nice to have someone, a face, face to the documents would be nice. So yeah, I think that it is very exciting to have that process possibly come into play for us and just alleviate that kind of stressor." Sunshine-based parents Danika and her husband Joel, made the shift to homeschooling in 2022 after Ben's classroom anxiety reached a tipping point. Danika is among thousands of Queensland parents who moved to homeschool their children after 2020, with the Queensland government saying there was a 230% increase in home education over the past 5 years. It brings the current number of homeschooling students in Queensland to more than 11,000. Brisbane-based Patricia Fitzgerald is campaign manager of the Free2Homeschool movement, which gathered more than 21,000 signatures opposing the former Queensland government's attempts to enforce the Australian curriculum on homeschoolers. She says the government's decision to accept all of the report's recommendations is a great move forward for the community. 'I just think that with the reviews, the recommendations that have been proposed, it's going to be a really good opportunity for the HEU to connect with the community and build that connection and more support rather than just having the regulatory side. Having that educational leader there to bridge that gap and to build that supportive side as well is going to help a lot of the families who are trying to find that information and trying to find the community." Ms Fitzgerald pointing to the first of the recommendations - to transform the Home Education Unit, which will be renamed Queensland Home Education, to ensure greater practical support and regulatory oversight. There are hopes the appointment of education leader Dr Renae Acton will improve processes for families, alongside enhancing resources, such as program templates and exemplar annual reports. Queensland's Education Minister John-Paul Langbroek told SBS he supports a parent's right to choose the best type of education for their family. "We as a government support choice, I've done distance education myself or correspondence as we called it, partly because I lived in another country in Papua New Guinea. And the important thing is that if parents choose to do it, we want to make sure we support them just as we support them in the other frames of schooling that they might choose, whether it's state or non-state schooling." Minister Langbroek couldn't outline a date for when the recommendations would be legislated, saying his government prioritises consultation. This comes as legislation to raise the age cut-off from 17 to 18 for homeschooling students is still under review, after it was tabled in March. But Mr Langbroek says some of the recommendations from the regulatory review are already being enacted - including changing the name of the unit to Queensland Home Education, as well as extending the stakeholder consultation via the Home Education Expert group, by another six months. "We used to criticise the former government for consulting but already having made a decision about something. So this is genuine consultation with the group, so we want to keep the momentum going about the positive work we've been able to do with parents and stakeholders, and then continue parent engagement before we try to make any legislative change." One of the key aspects of the recommendations is to enhance resources and supportive tools for parents meeting regulatory requirements. Danika welcomes access to learning programs and reporting scaffolds, which are particularly helpful in teaching a neurodiverse child with individualised learning. "The learning plan that I have for Ben being neurodiverse, we very much follow his interests at the time. And having an online reporting scaffolding will really help me just report as we learn because we do have a plan in place, but obviously following just natural interests and natural ways of learning, it does change as we go. So having a formalised reporting structure will help us just keep tabs on where we're at and what we're learning and how we're learning it." But she would like to see state and local governments offer greater support for homeschooling co-ops, which allow groups of homeschooling families to collaborate and provide educational and social opportunities for their children. "We really need the support from local government backed by, sorry local councils backed by government, to ensure that we are setting up safe spaces for our children. All the boxes are being ticked to keep it a safe environment for our children and that they can continue to build regular foundational relationships within those groups instead of being shut down every couple of months because local councils are getting one complaint from someone who doesn't agree with the way that we are teaching our children. So I think that's another way that the government could help us all support us on our journey." The Queensland Family and Child Commission released a separate report in December 2024, in response to concerns raised by the Child Death Review Board in their 2022-2023 report. It "affirmed a parent's right to choose the most suitable learning environment for their child", but called for improved information-sharing between state government departments to ensure child safety. Minister Langbroek told SBS that his government are considering the work of the Queensland Family and Child Commission, acknowledging past obstacles around information sharing.
"And Premier Crisafulli has been very clear that he wants me as education minister working closely with the Child Safety Minister Amanda Camm, the Attorney General Deb Frecklington, and
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health Check: Neuren says the US Rett syndrome market is a case of glass half full
Health Check: Neuren says the US Rett syndrome market is a case of glass half full

News.com.au

time40 minutes ago

  • News.com.au

Health Check: Neuren says the US Rett syndrome market is a case of glass half full

Neuren's US partner Acadia reports a 14% sales boost Look out for a slew of advanced clinical trial results in early 2026 IDT Australia shares plunge up to 39% after CEO departs 'with immediate effect' Despite firming US sales of its Rett syndrome treatment Daybue, Neuren Pharmaceuticals (ASX:NEU) says two-thirds of eligible patients are yet to try the drug. Neuren's US partner Acadia Pharmaceuticals overnight reported quarterly net sales of US$96.1 million, up 14% year on year. The Nasdaq-listed Acadia says a record number of patients received a shipment, growing for the third consecutive quarter. Acadia holds the global rights to Daybue and pays royalties to Neuren, which initially developed the drug. Affecting boys, Rett syndrome is a rare neurodevelopmental disorder resulting in slow development after the ages of six to 18 months. Acadia has guided to net sales of US$380-405 million, which at the current exchange rate will generate $62-67 million of royalties for Neuren in calendar 2025. Neuren earned $14.7 million in the June quarter, up 16% year on year. By their nature, royalties are pretty much pure profit. More patients – and they're more persistent Acadia says a record 987 patients received Daybue in the quarter, up from 954 in the March quarter. Despite concerns about side effects, 50% of patients persisted after 12 months' treatment. Neuren adds that 70% of active patients have now been on therapy for 12 months or longer. This was up from 65% previously. The company says two-thirds of the 5500 to 5800 diagnosed US patients are yet to try Daybue. The FDA approved the therapy in March 2023 and Acadia expects European assent in the March 2026 quarter. Neuren shares this morning spurted as much as 8%. They've more than doubled since their mid-April trough of $8.60. Investors spoil IDT's golden jubilee Veteran contract drug maker IDT Australia's (ASX:IDT) golden jubilee has been spoiled by a savage share rout, resulting from the news that CEO Paul McDonald would depart 'with immediate effect'. The company also issued a lacklustre trading update, flagging a boost in revenue for the year to June 30, 2025, but a widening loss. A former Pfizer exec, McDonald had been in the job for almost three years. Chairman Mark Simari becomes executive chair while the company searches for a new CEO. IDT says its full-year revenue should come in at $19.9 million, a 40% increase. The company cites an increase in disbursement revenue. This derived from raw material costs and equipment charged to customers at a 'modest' margin. IDT says mainly applying to new contracts, disbursements are a 'positive lead indicator'. IDT also expects a net loss of $7.5 million, compared with a $5.4 million deficit last year. This reflects $1.2 million of bad debts from two customers defaulting on payments. Founded in 1975, IDT has had a convoluted history, including missing out on a government funded Covid vaccine plant at the last minute. These days IDT pursues gene technology, antibody drug conjugates, medical marijuana and psychedelic treatments for mental disorders. The company is in the third year of its five-year strategy, spurred by a board 'refresh' in September 2022. IDT's $30 million worth is backed by the value of the company's Boronia premises in eastern Melbourne. This hard-to-replicate is in the books at a conservative $21 million. We're on track, say drug developers Investors can look forward to a slew of company-making trial results in 2026, according to presenters at this year's Bioshares summit in Hobart. Alzheimer's disease drug developer Actinogen Medical (ASX:ACW) says it's on track to report interim results from its advanced phase IIb/III trial, by January next year. The company is enrolling 220 patients for its Xanamia trial for mild to moderate sufferers, across 15 Australian and 20 US sites. Actinogen's candidate Xanamem targets excess levels of cortisol in the brain – a novel mechanism of action. The company expects to unveil data from the first 100 patients, after 24 weeks' treatment. Final results are expected in late 2026. Stem cell developer Cynata Therapeutics (ASX:CYP) expects to release results of its phase III osteoarthritis (OA) trial between February and April next year. Cynata's mesenchymal stromal cells modulate the immune system and enable tissue repair. The OA program is the most advanced of Cynata's four trials that also cover graft-versus-host disease, diabetic foot ulcers and kidney transplants. Vitiligo is a circa US$500 million market, says Clinuvel The developer of an approved treatment for a rare sun intolerance disorder abbreviated as EPP, Clinuvel Pharmaceuticals (ASX:CUV) is advancing its proposed treatment for the more common vitiligo. The company has fully enrolled its 210 patient phase III trial, with a readout due in the June half. Affecting about 1% of the population, vitiligo is skin discolouration that results from the destruction of pigment-producing cells called melanocytes. The late Michael Jackson was a celebrity sufferer. If the drug gets US Food and Drug Administration (FDA) approval, the company estimates US$490-570 million of revenue in years one and two. Put in context, Clinuvel reported revenue of $35.6 million in the 2024 December half, up 10%. These sales derived from the company's EPP treatment, Scenesse. Doing the numbers on Imricor Broker Canaccord reckons Imricor Medical Systems (ASX:IMR) could be worth more than twice its current valuation – but faces constrained hospital budgets for the time being. In a 60-page appraisal of the cardiac ablation catheter developer, the firm estimates 120 US hospitals could be using the device within five years. Assuming 35% penetration of the ablation procedures, this equates to a $2.50 per share valuation compared with around $1.40 now. 'The big question ... is how quickly can these installs happen,' the firm says. Uniquely, Imricor's catheters are guided in real-time with magnetic resonance imaging – MRI – rather than via x-ray. The procedure is called interventional cardiac magnetic resonance cardiac ablation (ICMR CA). The company initially is focused on the US$12b arrhythmia market. Canaccord believes Imricor is still 12-18 months away from a 'material revenue ramp'. But after that it's off to the races. Imricor has an initial US target market as 120 large academic hospitals, 20 of them high volume. The firm estimates that facilities will install 190 ICMR US labs globally five years post launch. Of these, 100 will be in the US with total revenue of US$250 million. Imricor currently is undertaking a trial aimed at FDA approval for atrial flutter procedures, with a decision by the end of 2026.

Indonesian protesters call for Australia to stop sending plastic waste as microplastic found in foetuses
Indonesian protesters call for Australia to stop sending plastic waste as microplastic found in foetuses

News.com.au

timean hour ago

  • News.com.au

Indonesian protesters call for Australia to stop sending plastic waste as microplastic found in foetuses

Furious scenes have erupted outside an Australian embassy overseas, with protesters claiming their babies are being 'poisoned'. Environmental activists in the Indonesian city of Surabaya have demanded Australia stops sending plastic waste to Indonesia, arguing the contaminated waste has developed micro plastics in foetuses. Protesters dragged two large dolls in front of the Australian Consulate-General to depict a scene of babies engulfed by contaminated plastic waste, and a mannequin of a pregnant mother. They arrived also with masks, signs and a megaphone relaying their message. 'Australia's plastic waste is poisoning out babies,' one sign read. 'Your plastic lifestyle destroys babies' future,' another read. The news comes as Ecological Observation and Wetland Conservation (ECOTON) recently revealed Australia was the largest exporter of plastic waste to Indonesia between 2020 and 2024, sending more than 2.7 billion kilograms, according to the UN Comtrade Database. It also found more than 60 per cent of paper waste sent from Australia to Indonesia was contaminated either by flexible plastics scrap, multilayer plastic or soiled plastic packaging. Such materials cannot be recycled and end up building up at illegal dump sites. Even more concerning, in late 2014 ECOTON tested more than 80 baby care products and found nearly 60 per cent of them contained microbeads, which are tiny plastics that enter the body through the skin. 'We found that microplastics were already present in the foetus,' one protester said. 'Then our findings show they were in the placenta, meaning these small plastic particles were already able to penetrate the placenta and also the amniotic fluid. 'Now, this can be concerning for the future of this nation's life.' The move aims to put pressure on the Australian government to reconsider how it disposes of plastic waste and the impact on the Indonesian people. It's another push drawing attention to the matter that has become a big talking point Indonesia, with protests becoming almost routine. Protesters organised a similar event last year in July when the 'Your Trash Drowns Us' protest was held in the same spot outside the embassy, demanding the Australian government to stop sending plastic waste that was impacting the environment in East Java. 'I've heard of the concept of Laudato Si' from Pope Francis. Are we going there? Hopefully,' Indonesian environmentalist Prigi Arisandi said. Laudato Si', the then-pope's encyclical from 2015, stressed the international obligation to take care of the environment, with a call for ecological conversion.

Brandy production returns to Coonawarra as winery revives distilling heritage
Brandy production returns to Coonawarra as winery revives distilling heritage

ABC News

time2 hours ago

  • ABC News

Brandy production returns to Coonawarra as winery revives distilling heritage

For the first time in decades, brandy is returning to the Coonawarra. The region was once a major producer of the wine-based liquor, before it dropped out of fashion. The idea to bring back brandy to the Coonawarra came from the director of Majella Wines, Brian "Prof" Lynn. After contemplating launching a spirit, he thought brandy would be the most natural progression from wine. It has so far been a straightforward addition for the business, requiring only a distillation still in addition to their existing wine, rainwater and wooden ageing barrels. Mr Lynn has found the distilling process to be quick, only taking about six hours. But the ageing process is slow, with all brandy legally required to be aged for two years in a wooden cask. Despite the strong historic origins of brandy in the region, Majella's release is the first to include the region on the labelling. In the early 1900s, tastes were changing and demand for dry reds dwindled. The brandy produced with the surplus grapes would eventually become generically branded brandy. But as other wine varieties grew in popularity, Coonawarra's brandy production declined and eventually stopped in the late 20th century. Much of the knowledge about Coonawarra brandy has been lost through the decades, but there are some in the region still with connections to the liquor. Coonawarra resident Diana Clayfield's father, Arthur Hoffmann, was a viticulturalist, wine and brandy maker in the region. "He enjoyed doing it [making brandy]," she said. Ms Clayfield remembers the generation before her enjoying a brandy, and sometimes even using it for medicinal purposes. "If you had a flu, they warmed brandy and wine up together and had it as a medicine," she said. It was this connection with medicine that helped brandy to become so popular, with production peaking in the 1960s. Luke McCarthy has extensively researched and written about Australian spirits and brandy. He said hospital brandy emerged around the turn of the 20th century, with major brands producing it into the 1940s. The term fell out of vogue around the same time brandy production declined. Another blow was the federal excise on brandy, facing a large increase in the 1970s to be closer to other spirits. "It's a combination of economic forces, government intervention and then shifting consumer trends, which have seen brandy really ride this sort of roller coaster ride over the last 100 years," Mr McCarthy said. Australian Distillers Association president Holly Klintworth said, although the market for other spirits like gin had become crowded, there was an opportunity ahead for brandy. "There's definitely a place in Australia for brandy and I hope that it's only a matter of time before more and more people start to rediscover just how amazing brandy can be," she said. And it could be a money spinner for wineries — Ms Klintworth's distillery turns "about $16,000 worth of wine into the equivalent of $1.5 million worth of brandy". "It makes a lot of sense. We've got so many wine regions," she said. Mr Lynn agrees that conditions are right for a comeback. He was already ageing a fresh batch of brandy to release in future years. "In the old days, brandy was huge; everyone drank brandy," he said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store